Homegrown FMCG maker Dabur India on Wednesday (November 15) said Dabur International Ltd and Dermoviva Skin Essentials Inc have been dismissed as defendants in federal cases before the United States District Court for the Northern District of Illinois.

Share Market Live

NSE

The dismissal was based on the lack of personal jurisdiction, as neither Dabur nor Dermoviva had any involvement in manufacturing, marketing, distributing, or selling hair relaxer products in the US.

Currently, Namaste Laboratories LLC remains the sole defendant in these cases, alongside other industry players such as L'Oreal, SoftSheen/Carson, Luster Products Inc, Avion Industries, Inc., PDC Brands (Parfums de Coeur, Ltd), and Revlon, among others.

Also Read: How Sula Vineyards plans to dominate the premium wine category

Dabur clarified that the lawsuit doesn't pertain to any Dabur brand or product, emphasising that Dabur India Ltd is not a party to these suits. The sale of hair relaxer products by Namaste constitutes less than 1% of the total consolidated turnover of Dabur India Ltd.

Namaste, expressing confidence in the safety of its products, denies any liability and has retained counsel to defend against the lawsuits.

The allegations are based on an unsubstantiated and incomplete study published in the journal of the National Institute of Health, a study already deemed redundant by the Cosmetic, Toiletry & Perfumery Association in the European Union.

Additionally, Namaste has product liability insurance cover in place to address potential damages, claims, and defense costs arising from the litigation. The company remains steadfast in its position that these lawsuits lack legal merit.

Also Read: Muthoot Finance expects 10-15 basis points increase in borrowing cost

Shares of Dabur India Ltd ended at ₹525.95, down by ₹4.20, or 0.79 percent on the BSE.